Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the … Continue reading FDA Advisory Committee Recommends Emergency Use Authorization of Novavax (NASDAQ: NVAX) COVID-19 Vaccine for People Aged 18 Years and Older